Zimbabwe has rejected a major US health deal valued at 367 million US dollars (£272m) spanning five years due to the United States' request for confidential data.
The decision was revealed following a internal memorandum from December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "lopsided".
A government representative has since explained that the US was demanding access to genetic material for scientific study and profit while was not willing to guarantee the benefits from any future treatments.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further talks to find a agreement agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This rejection comes after a similar situation in Kenya, where a court suspended a related deal with the US after concerns were filed about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government deals to boost transparency and accountability.
Based on statements, Sixteen African countries have so far signed these new agreements, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population if a new health crisis emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.
"This framework is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage continued discussions with our American counterparts on how future collaboration could be designed in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations should continue considering much of the nation's HIV programmes relied on external financing.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it commented.
The halted deal underscores the continuing debate between receiving crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.